Quantification of HER2 oncoprotein in fine-needle aspirates of the breast

Annals of Clinical and Laboratory Science

Volumn 30, Issue 1, 2000, Pages 49-56

  Wu, James T ^a,b   Zhang, Ping ^a   Bentz, Joel S ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b ARUP LABORATORIES   (United States)

Author keywords

Breast carcinoma; Ectodomain; Fine needle aspirate; HER2 oncoprotein; Herceptin; P185

Indexed keywords

TRASTUZUMAB;

ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; GENE ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; METASTASIS; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIFFERENTIATION;

BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CHROMATOGRAPHY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; RECEPTOR, ERBB-2;

EID: 0033973909     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Venter DJ, Tuzi NL, Kumar S et al. Overexpression of the c-erbB-2 protein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet 1987; 2:69-72.
2. Slamon DJ, Clark GM, Wong SG et al. Human breast cancer correlation of relapse and survival with amplification of the HER-2/c-erbB-2 oncogene. Science 1987; 235:177-182.
3. Berger MS, Locher GW, Saurer S et al. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 1988; 48:1238-1243.
4. Akiyama T, Sudo C, Ogawara H et al. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 1986; 232:1644-1646.
5. Schechter AL, Stern DF, Vaidyanathan L et al. The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumor antigen. Nature 1984; 312:513-516.
6. Slamon DJ, Godolphin W, Jones LA et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244:707-712.
7. van de Vijver MJ, Mooi WJ, Wisman P et al. Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA. Oncogene 1988; 2:175-178.
8. Press MF, Hung G, Godolphin W et al. Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 1994; 54:2771-2777.
9. Kopreski MS, Lipton A, Harvey H et al. Growth inhibition of breast cancer cell lines by combinations of anti-p185 HER2 monoclonal antibody and cytokines. Anticancer Res 1996; 16:433-436.
10. HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol 1998; 16:2659-2671.
11. Vetto JT, Pommier RF, Schmidt WA et al. Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective. Arch Surg 1996; 131:967-974.
12. De Placido S, Carlomagno C, De Laurentiis M et al. C-erbB2 expression predicts tamoxifen efficacy in breast cancer patients. Breast Cancer Res Treat 1998; 52:55-64.
13. Tandon AK, Clark GM, Chamness GC et al. HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 1989; 7:1120-1128.
14. Donegan WL. Evaluation of a palpable breast mass. N Engl J Med 1992; 327:937-942.
15. Skoog L, Anbarlo J, Wilking N et al. c-erbE-2 and steroid receptors in carcinoma cells obtained by fine-needle aspiration from primary breast carcinomas during tamoxifen treatment. Diagn Oncol 1992; 2:327-331.
16. Wu JT, Zhang P, Astill ME et al. Identification and characterization of c-erbB-2 proteins in serum, breast tumor tissue, and Sk-BR-3 cell line. J Clin Lab Anal 1995; 9:141-150.
17. Carney WP, Hamer PJ, Petit D. Detection and quantitation of the human c-erbB-2 protein. J Tumor Marker Oncol 1991; 6:53-72.
18. Nugent A, McDermott E, Duffy K, O'Higgins N, Fennelly JJ, Duffy MJ. Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancer. Clin Chem 1992; 38:1471-1474.
19. Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koerner F et al. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 1994; 330:1260-1266.
20. American Society of Clinical Oncology. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 1996; 14:2843-2877.